诺为泰（Novotech）：2024帕金森病：全球临床试验概况报告（中译版）（22页）.pdf

1、novotech-12 November 2024Parkinsons Disease-Global Clinical Trial Landscape(2024)The PD treatment market ofers diverse products by compa-nies including like Abbott Laboratories,AbbVie Inc.,Boston Scientific Corp,and InSightec Ltd.Ongoing trials across all stages are advanc-ing PD treatment through s

2、mall mole-cules,proteins,cell,and stem cell thera-pies,led by companies like Amgen,BeiGene,Novo Nordisk,and Hope BiosciencesCountries like Mainland China,the United States,the United Kingdom,Japan,Russia,Spain,and Australia emerged as top locations for conducting trialsEurope showed faster recruitme

3、nt durations and patient recruitment ratesParkinsons DiseaseTRIAL CONTRIBUTIONS2ndMOSTCOMMON NEURO-DEGENERATIVEDISORDERPARKINSONSDISEASE(PD)IS THEThe content of this publication is proprietary to Novotech Health Holdings.No part of this publication may be reproduced,distributed,or transmitted in any

4、 form or by any means,including photocopying,recording,or other electronic or mechanical methods,without the prior written permission of Novotech except in the case of quotations embodied in reviews and non-commercial uses.Please note that this copyright statement applies specifically to this public

5、ation and its content and does not extend to other materials or intellectual property owned by Novotech.Any unauthorized reproduction or distribution of this publication or any portion thereof may result in legal action taken by Novotech to protect its rights.For permissions or inquiries,please cont

6、act:communicationsnovotech-#DYK Did youknow?The Asia-Pacific region bears a high PD burden,with China reporting over 3 million casesIn North America,the United States reported higher PD casesIn Europe,the PD incidence numbers show a considerable impact,with Germany,Russia,Italy,and France leading in